Sat, 14 Oct 2023 03:00:48 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/increased-exposure-to-pfas-phenols-linked-to-prior-cancer-diagnosis/ Mon, 02 Oct 2023 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=110894 Greater PFDE, PFNA, and PFUA associated with increased odds of previous melanoma.]]> https://www.oncologynurseadvisor.com/home/departments/radiation-and-your-patient/proton-flash-radiotherapy-deemed-feasible-comparable-to-conventional-dose-rate-radiotherapy/ Thu, 03 Nov 2022 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=103060 Proton FLASH radiotherapy is feasible, safe, and provides pain relief for cancer patients with bone metastases, according to a first-in-human trial.]]> https://www.oncologynurseadvisor.com/home/cancer-types/head-and-neck-cancer/active-surveillance-feasible-for-low-risk-thyroid-cancer/ Thu, 29 Sep 2022 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=102318 Patients undergoing immediate surgery experience greater anxiety than patients in active surveillance.]]> https://www.oncologynurseadvisor.com/home/cancer-types/head-and-neck-cancer/thyroid-cancer-often-detected-in-asymptomatic-patients/ Fri, 16 Sep 2022 14:30:00 +0000 https://www.oncologynurseadvisor.com/?p=100959 Many thyroid cancers are discovered in patients who undergo surgery without thyroid-referable symptoms, an international study suggests.]]> https://www.oncologynurseadvisor.com/home/cancer-types/head-and-neck-cancer/more-thyroid-cancers-idd-in-patients-with-no-symptoms/ Mon, 25 Jul 2022 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=100831 Forty-six percent of patients who underwent thyroid-directed surgery had cancer; of these, 51 percent were asymptomatic.]]> https://www.oncologynurseadvisor.com/home/cancer-types/head-and-neck-cancer/significant-financial-burden-thyroid-cancer-treatment-risk/ Wed, 18 May 2022 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=99128 An analysis of studies in the literature sought to determine the financial burden patients with thyroid cancer incur from diagnosis, treatment, and surveillance.]]> https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/cancer-specific-death-risk-may-remain-elevated-30-years/ Thu, 12 May 2022 14:45:00 +0000 https://www.oncologynurseadvisor.com/?p=99010 Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.]]> https://www.oncologynurseadvisor.com/home/cancer-types/head-and-neck-cancer/multifocality-papillary-thyroid-carcinoma-recurrence/ Tue, 31 Aug 2021 15:16:43 +0000 https://www.oncologynurseadvisor.com/?p=94590 The risk of recurrence varied by patient age, tumor size, and number of foci.]]> https://www.oncologynurseadvisor.com/home/cancer-types/pancreatic-cancer/vandetanib-cabozantinib-thyroid-cancer-treatment-risk-effective/ Wed, 28 Jul 2021 12:00:00 +0000 https://www.oncologynurseadvisor.com/?p=93696 The overall survival rate at 1 year was 86% with vandetanib and 70% with cabozantinib.]]> https://www.oncologynurseadvisor.com/home/cancer-types/pancreatic-cancer/local-resection-sufficient-parathyroid-carcinoma-treatment-risk/ Wed, 21 Jul 2021 15:14:46 +0000 https://www.oncologynurseadvisor.com/?p=93507 Patients with parathyroid carcinoma after localized resection for a presumed benign indication should undergo close monitoring for recurrence rather than radical surgery. ]]>